US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 238.260
  • +4.410+1.89%
Close Apr 29 16:00 ET
  • 238.260
  • 0.0000.00%
Post 16:00 ET
11.21BMarket Cap12.03P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
14.88%1.94B
18.38%491.5M
16.03%516M
4.57%466.9M
21.84%461.9M
Operating revenue
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
14.88%1.94B
18.38%491.5M
16.03%516M
4.57%466.9M
21.84%461.9M
Cost of revenue
69.85%257.5M
20.75%71M
88.44%70.1M
115.82%64.1M
101.93%52.3M
23.76%151.6M
69.94%58.8M
34.30%37.2M
-20.16%29.7M
12.61%25.9M
Gross profit
15.99%2.07B
25.65%543.7M
12.64%539.3M
21.77%532.4M
4.27%454.6M
14.18%1.78B
13.69%432.7M
14.82%478.8M
6.82%437.2M
22.44%436M
Operating expense
9.95%885.1M
10.31%283.6M
29.06%212.3M
-6.97%219M
15.00%170.2M
-20.07%805M
21.96%257.1M
-12.64%164.5M
25.82%235.4M
-64.84%148M
Selling and administrative expenses
-1.04%477.1M
-19.00%132.2M
29.67%127.6M
-8.13%130M
10.51%87.3M
3.23%482.1M
27.60%163.2M
-9.81%98.4M
25.44%141.5M
-32.59%79M
-Selling and marketing expense
15.54%81.8M
4.78%24.1M
20.35%20.7M
24.84%20.1M
16.55%16.9M
9.94%70.8M
40.24%23M
0.00%17.2M
-5.85%16.1M
5.84%14.5M
-General and administrative expense
-3.89%395.3M
-22.90%108.1M
31.65%106.9M
-12.36%109.9M
9.15%70.4M
2.16%411.3M
25.74%140.2M
-11.64%81.2M
31.03%125.4M
-37.68%64.5M
Research and development costs
26.35%408M
61.24%151.4M
28.14%84.7M
-5.22%89M
20.14%82.9M
-40.21%322.9M
13.27%93.9M
-16.54%66.1M
26.38%93.9M
-77.28%69M
Operating profit
20.95%1.18B
48.12%260.1M
4.04%327M
55.30%313.4M
-1.25%284.4M
76.24%979.7M
3.42%175.6M
37.43%314.3M
-9.18%201.8M
544.44%288M
Net non-operating interest income expense
707.81%103.4M
322.35%35.9M
624.39%29.7M
3,633.33%22.4M
3,950.00%15.4M
773.68%12.8M
1,800.00%8.5M
612.50%4.1M
185.71%600K
-500.00%-400K
Non-operating interest income
259.96%162.7M
145.19%51M
240.60%45.3M
447.06%37.2M
579.07%29.2M
170.66%45.2M
395.24%20.8M
250.00%13.3M
70.00%6.8M
-8.51%4.3M
Non-operating interest expense
83.02%59.3M
22.76%15.1M
69.57%15.6M
138.71%14.8M
193.62%13.8M
74.19%32.4M
161.70%12.3M
100.00%9.2M
31.91%6.2M
2.17%4.7M
Other net income (expense)
66.59%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-137.44%-7.9M
-205.01%-41.9M
81.60%-5.3M
74.89%-5.9M
-936.00%-51.8M
-78.29%21.1M
Special income (charges)
--0
--0
--0
--0
--0
26.09%-1.7M
--0
--0
--0
---1.7M
-Write off
--0
--0
--0
--0
--0
-26.09%1.7M
--0
--0
--0
--1.7M
Other non- operating income (expenses)
65.17%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-134.65%-7.9M
-195.26%-40.2M
81.60%-5.3M
74.89%-5.9M
-1,818.52%-51.8M
-76.54%22.8M
Income before tax
34.05%1.27B
65.21%295.4M
12.58%351.8M
122.58%335.2M
-5.44%291.9M
60.06%950.6M
27.26%178.8M
52.89%312.5M
-30.44%150.6M
849.85%308.7M
Income tax
29.65%289.5M
67.67%78.3M
15.03%84.2M
119.65%76M
-25.87%51M
89.08%223.3M
65.02%46.7M
75.54%73.2M
-21.18%34.6M
1,538.10%68.8M
Net income
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
747.70%239.9M
Net income continuous Operations
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
747.70%239.9M
Minority interest income
Net income attributable to the parent company
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
747.70%239.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
52.86%727.3M
17.74%132.1M
47.08%239.3M
-32.79%116M
747.70%239.9M
Basic earnings per share
31.66%21.04
60.42%4.62
8.56%5.71
116.02%5.53
-2.07%5.2
50.75%15.98
15.66%2.88
45.30%5.26
-33.51%2.56
742.86%5.31
Diluted earnings per share
32.07%19.81
63.30%4.36
9.57%5.38
117.43%5.24
-3.38%4.86
49.11%15
13.62%2.67
43.57%4.91
-33.97%2.41
724.59%5.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M14.88%1.94B18.38%491.5M16.03%516M4.57%466.9M21.84%461.9M
Operating revenue 20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M14.88%1.94B18.38%491.5M16.03%516M4.57%466.9M21.84%461.9M
Cost of revenue 69.85%257.5M20.75%71M88.44%70.1M115.82%64.1M101.93%52.3M23.76%151.6M69.94%58.8M34.30%37.2M-20.16%29.7M12.61%25.9M
Gross profit 15.99%2.07B25.65%543.7M12.64%539.3M21.77%532.4M4.27%454.6M14.18%1.78B13.69%432.7M14.82%478.8M6.82%437.2M22.44%436M
Operating expense 9.95%885.1M10.31%283.6M29.06%212.3M-6.97%219M15.00%170.2M-20.07%805M21.96%257.1M-12.64%164.5M25.82%235.4M-64.84%148M
Selling and administrative expenses -1.04%477.1M-19.00%132.2M29.67%127.6M-8.13%130M10.51%87.3M3.23%482.1M27.60%163.2M-9.81%98.4M25.44%141.5M-32.59%79M
-Selling and marketing expense 15.54%81.8M4.78%24.1M20.35%20.7M24.84%20.1M16.55%16.9M9.94%70.8M40.24%23M0.00%17.2M-5.85%16.1M5.84%14.5M
-General and administrative expense -3.89%395.3M-22.90%108.1M31.65%106.9M-12.36%109.9M9.15%70.4M2.16%411.3M25.74%140.2M-11.64%81.2M31.03%125.4M-37.68%64.5M
Research and development costs 26.35%408M61.24%151.4M28.14%84.7M-5.22%89M20.14%82.9M-40.21%322.9M13.27%93.9M-16.54%66.1M26.38%93.9M-77.28%69M
Operating profit 20.95%1.18B48.12%260.1M4.04%327M55.30%313.4M-1.25%284.4M76.24%979.7M3.42%175.6M37.43%314.3M-9.18%201.8M544.44%288M
Net non-operating interest income expense 707.81%103.4M322.35%35.9M624.39%29.7M3,633.33%22.4M3,950.00%15.4M773.68%12.8M1,800.00%8.5M612.50%4.1M185.71%600K-500.00%-400K
Non-operating interest income 259.96%162.7M145.19%51M240.60%45.3M447.06%37.2M579.07%29.2M170.66%45.2M395.24%20.8M250.00%13.3M70.00%6.8M-8.51%4.3M
Non-operating interest expense 83.02%59.3M22.76%15.1M69.57%15.6M138.71%14.8M193.62%13.8M74.19%32.4M161.70%12.3M100.00%9.2M31.91%6.2M2.17%4.7M
Other net income (expense) 66.59%-14M88.68%-600K16.95%-4.9M98.84%-600K-137.44%-7.9M-205.01%-41.9M81.60%-5.3M74.89%-5.9M-936.00%-51.8M-78.29%21.1M
Special income (charges) --0--0--0--0--026.09%-1.7M--0--0--0---1.7M
-Write off --0--0--0--0--0-26.09%1.7M--0--0--0--1.7M
Other non- operating income (expenses) 65.17%-14M88.68%-600K16.95%-4.9M98.84%-600K-134.65%-7.9M-195.26%-40.2M81.60%-5.3M74.89%-5.9M-1,818.52%-51.8M-76.54%22.8M
Income before tax 34.05%1.27B65.21%295.4M12.58%351.8M122.58%335.2M-5.44%291.9M60.06%950.6M27.26%178.8M52.89%312.5M-30.44%150.6M849.85%308.7M
Income tax 29.65%289.5M67.67%78.3M15.03%84.2M119.65%76M-25.87%51M89.08%223.3M65.02%46.7M75.54%73.2M-21.18%34.6M1,538.10%68.8M
Net income 35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M747.70%239.9M
Net income continuous Operations 35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M747.70%239.9M
Minority interest income
Net income attributable to the parent company 35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M747.70%239.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M52.86%727.3M17.74%132.1M47.08%239.3M-32.79%116M747.70%239.9M
Basic earnings per share 31.66%21.0460.42%4.628.56%5.71116.02%5.53-2.07%5.250.75%15.9815.66%2.8845.30%5.26-33.51%2.56742.86%5.31
Diluted earnings per share 32.07%19.8163.30%4.369.57%5.38117.43%5.24-3.38%4.8649.11%1513.62%2.6743.57%4.91-33.97%2.41724.59%5.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg